. 2014 Mar;52(3):844–848. doi: 10.1128/JCM.03143-13

TABLE 1.

Characteristics of women from the CAPRISA 004 trial analyzed for superinfection

Population characteristics (n = 76)	Median	IQR^a
Age (yr)	22	21–26
HIV viral load (log copies/ml)^a	4.7	3.9–5.2
CD4 count^a	476	401–647
Follow-up (yr)	1.9	1.1–2.2
% from tenofovir arm	38.2

Interquartile range (IQR), CD4 counts, and viral load were measured at initial time point screened for SI (median, 10 weeks from infection).